Human Interleukin-2 (Liangyuan Bioscience)
人白介素-2（良远生物）
Report date: 2025/06/10 17:04:13
Base Information
Drug NameHuman Interleukin-2 (Liangyuan Bioscience)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeijing Liangyuan Bioscience Llc
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesBeijing Liangyuan Bioscience Llc
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A